Header
Rhode Island
IDeA Network of Biomedical Research Excellence
INBRE Menu
RI-INBRE > Research Core > Molecular Toxicology > Karen Almeida

Karen Almeida

The Interactome of NAMPT:  The Influence of Energetics on DNA Repair (2011-Present)

Investigator:  Karen Almeida, Rhode Island College

Abstract:  Maintaining an accurate genome is critical for cellular survival.  Yet the genome is under constant assault from both endogenous and environmental agents that cuase DNA damage.  Therefore, cells have developed numerous pathways to repair damage to the DNA.  Persistent unrepaired DNA damage has severe consequences such as global genomic instability which is a unifying feaure of cancer cells. A marker of persistent DNA damage is the hyper-activation of the Poly(ADP-Ribose) polymerase (PARP) family of enzymes. PARP proteins detect single strand breaks in the DNA, bind the ends and catalyze the transfer of poly(ADP-ribose) chains (PAR) using NAD+ as the ADP-ribose source.  These long PAR chains recruit DNA repair proteins to the damage site, whereby initiating repair.  Once the DNA is restored, the PAR chains are degraded, allowing another ssDNA break event to be detected. Persistent damage leads to an overactivation of PARP, increased concentrations of PAR and a concomitant depletion of cellular NAD+ levels. NAD+ levels can be replenished by the ADP ribosylation of nicotinamide via the NAD+ salvage pathway. The rate-limiting enzyme in the salvage pathway is NAMPT (aka visfatin or PBEF).  NAMPT has been implicated in numerous human disorders including diabetes, ischemia, heart disease and cancer. NAMPT is a 55 KDa protein that forms a homodimer and has several phosphorylation sites, one of which (Y188) is located on the homodimerization plane. We propose to explore the influence of NAMPT on cellular pathways by first determining the phosphorylation status required for homodimerization.  Yeast-2-Hybrid analysis of a simulated interaction will be completed using NAMPT, NAMPT-Y188F (a mutant representing the non-phosphorylated protein), and NAMPT-Y188D (a mutant that mimics the phosphorylated tryrosine residue). We further propose to identify a set of interacting partners of NAMPT using a Y2H approach against a cDNA library.  Currently there are only six proteins known to interact with NAMPT. The result will give insights into the possible reasons for dimerization, identify multiple interacting partners of NAMPT and assist in the targeting of cellular energetics for drug development.

News & Events

Newsletter

RI-INBRE Newsletter Winter 2013

Grant Workshop PowerPoint Presentations & Handouts

Balancing Teaching and Research at PUIs


Components of a Successful AREA (R15) Grant


NSF-RUI Program: Strategies and Tips for Success


Handouts

Important Dates & Announcements

RI-INBRE Calendar


RI-INBRE News


NIH Public Access Policy


NIH R15 Submission Deadlines - June 25, October 25, & February 25

3/22/2013 - "Revealing Nonobvious Features in Noncoding Human DNA - Insights for Evolution, Gene Expression and Disease" by Laura Elnitski, Ph.D., National Human Genome Institute, National Institutes of Health


8/14/2013-8/16/2013 - 5th Northeast Regional IDeA Meeting, University of Delaware, Newark, DE


4th Northeast Regional IDeA Meeting, Salve Regina University, Newport, RI


RI Inbre Research Fellows

Promote Your Page Too  

 

 Supported by grant #  P20RR016457 from:

 

Contact Info
Contact RI INBRE:  
University of Rhode Island
495J, College of Pharmacy
| 7 Greenhouse Road | Kingston, RI 02881
Phone: (401) 874-9288 | Fax: (401) 874-2646 | E-mail: riinbre@etal.uri.edu